OTTAWA, Ontario–(BUSINESS WIRE)– Avivagen Inc. (TSXV:VIV, OTCQB: VIVXF) (‘Avivagen’), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, is pleased to announce that one of its most important customers in Asia has placed a new order for four tonnes of OxC-BetaTM Livestock to be used in Asia, in line with previous shipments fulfilled in 2021.
Avivagen Announces Receipt of Repeat Order from Asian Customer stars
